NFSG
ELV icon

Newbridge Financial Services Group’s Elevance Health ELV Stock Holding History

Newbridge Financial Services Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed -$5.38K – 1213
2023
Q3 		$5.38K Sell
12
-87
-88% -$39.5K ﹤0.01% 938
2023
Q2 		$43.8K Buy
99
+52
+111% +$24K 0.02% 490
2023
Q1 		$21.8K Buy
47
+10
+27% +$4.76K 0.01% 681
2022
Q4 		$19.1K Buy
37
+25
+208% +$12.7K 0.01% 735
2022
Q3 		$6K Sell
12
-21
-64% -$10K ﹤0.01% 999
2022
Q2 		$16K Sell
33
-1
-3% -$495 0.01% 722
2022
Q1 		$17K Sell
34
-10
-23% -$4.57K 0.01% 771
2021
Q4 		$20K Buy
44
+8
+22% +$3.37K 0.01% 724
2021
Q3 		$13K Hold
36
– – 0.01% 795
2021
Q2 		$14K Hold
36
– – 0.01% 875
2021
Q1 		$13K Buy
36
+20
+125% +$6.43K 0.01% 810
2020
Q4 		$5K Hold
16
– – ﹤0.01% 843
2020
Q3 		$4K Buy
+16
New +$4.3K ﹤0.01% 840

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Newbridge Financial Services Group's ELV Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 12 shares — an estimated $5.38K sold.

Newbridge Financial Services Group first reported a position in ELV in Q3 2020 and held it in 13 quarters. The position peaked at $43.8K in Q2 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 12 Elevance Health shares in Q4 2023, an estimated $5.38K.
  • Newbridge Financial Services Group first reported a position in Elevance Health in Q3 2020 and held it in 13 quarters.
  • Newbridge Financial Services Group's Elevance Health position peaked at $43.8K in Q2 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.